Veeva (VEEV) Forward Price-to-Revenue Multiple

Veeva Systems Inc. (VEEV) is growing as an organic monopolist by integrating its services into clients' R&D processes. The high scalability of its cloud software and recurring payments provide excellent operating leverage. The forward P/S multiple reflects market sentiment dynamics, with the current level at 8.70. Its status as the leading provider of IT solutions for biopharmaceuticals allows the company to effectively diversify risks when managing clinical data.

VEEV Veeva Systems: Market Cap to Expected Sales Ratio in the range 07/04/2022 - 11/13/2026

VEEV (Veeva Corp): analytical breakdowns and indicator data

- market price and analyst price targets:

Price Chart Veeva|VEEV - Analyst Median Target

- market capitalization details:

Market Valuation Veeva Corp|VEEV - Total Enterprise Value

- business book valuation details:

Net Assets per Single Share Veeva|VEEV - Book Valuation of Business|Market Cap to Net Assets Ratio veeva.com|VEEV - Aggregate Business Assets

- debt and liquidity data:

- business earnings and investment ratios data:

VEEV - Net Financial Result|Expected Profit Veeva Systems Inc.|VEEV - Price to Earnings Multiple|Forward P/E Multiple Veeva Systems Inc|VEEV - Price/Earnings to Growth Multiple|Enterprise Value to EBITDA Ratio Veeva Corp|VEEV - Operating income before deduction of amortization|Net earnings per share for the last 12 months Veeva|VEEV - Earnings per share for the last twelve months|Quarterly EPS earnings growth veeva.com|VEEV - Earnings per share growth rate in current year|Earnings growth forecast for next year Veeva Systems Inc.

- sales volume and revenue indicators:

VEEV - Company Total Revenue|Company Future Sales Volume Veeva|VEEV - Price-to-Revenue Ratio|Forward P/S Multiple Veeva Corp

Analysis of all company metrics:VEEV (Veeva)

The forward P/S ratio compares the current market value of Veeva Systems Inc. (VEEV) with expected revenues, determining the premium the market is willing to pay per unit of projected revenue. By analyzing the forward P/S history, an investor can see how the defensive profile of cloud software for the pharmaceutical sector smooths valuation volatility during crisis periods. The stability of clients' R&D budgets confirms the asset's high fundamental resilience, even at extreme multiple levels.

Analysis of competing companies

Price-to-Projected Revenue Ratio Doximity DOCS|Market Cap to Expected Sales Ratio HealthEquity Inc (HQY)|WAY: Forward Price-to-Revenue Multiple|Market Cap to Future Revenue Ratio CorVel Corp.|Privia Health Group (PRVA) - Price-to-Projected Revenue Ratio|HURN - Market Cap to Expected Sales Ratio|Forward Price-to-Revenue Multiple CERT|OMCL (Omnicell Inc) - Price to Expected Revenue Ratio|Forward P/S Multiple GDRX|SDGR - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio Phreesia, Inc. PHR|OMDA - Forward Price-to-Revenue Multiple|EVH - Price-to-Projected Revenue Ratio|Market Cap to Expected Sales Ratio HealthStream Inc HSTM|DH (Definitive Healthcare Inc.) - Forward Price-to-Revenue Multiple|Consensus Corp - Forward Price to Sales|AGL (Agilon Health) - Forward P/S Multiple|absci.com (ABSI) - Market Cap to Expected Sales Ratio|Price-to-Projected Revenue Ratio So-Young International Inc. (SY)|NRC Health - Market Cap to Projected Revenue|Forward P/S Multiple SPOK (Spok Corp)|OPRX - Forward Price-to-Revenue Multiple|TBRG: Forward Price-to-Revenue Multiple|Market Cap to Expected Sales Ratio simulations-plus.com SLP|SOPH (sophiagenetics.com) - Forward Price-to-Revenue Multiple|HCAT (Health Catalyst Inc.) - Price-to-Projected Revenue Ratio|CCLD (CareCloud Inc.) - Forward P/S Multiple|Market Cap to Future Revenue Ratio Research Solutions Inc. RSSS|Forward P/S Multiple DLHC|ONMD - Market Cap to Future Revenue Ratio|Scienture - Forward Price-to-Revenue Multiple|Healthcare Triangle Inc - Price-to-Projected Revenue Ratio|iSpecimen Corp - Forward P/S Multiple|Market Cap to Expected Sales Ratio Bullfrog AI Holdings BFRG|WORX (SCWorx Corp.) - Forward Price-to-Revenue Multiple|MSPR: Price to Expected Revenue Ratio|Forward Price-to-Revenue Multiple ICCT|MEDS: Forward Price to Sales|Price-to-Projected Revenue Ratio Orgenesis Corp (ORGS)|Forward Price-to-Revenue Multiple r1rcm.com RCM|Forward P/S Multiple SHCR (Sharecare, Inc.)|streamlinehealth.net (STRM) - Market Cap to Future Revenue Ratio|Syra Health - Forward P/S Multiple|AMEH (Apollo Medical Holdings) - Market Cap to Projected Revenue|MODN (Model N Corp) - Forward Price-to-Revenue Multiple|NXGN (NextGen Healthcare Corp) - Price-to-Projected Revenue Ratio